Credit Suisse Initiates Coverage On Tivity Health with Neutral Rating, Announces $22 Price Target

Credit Suisse analyst Jailendra Singh initiates coverage on Tivity Health (NASDAQ:TVTY) with a Neutral rating and a $22 price target.

Benzinga · 01/03/2020 12:10

Credit Suisse analyst Jailendra Singh initiates coverage on Tivity Health (NASDAQ:TVTY) with a Neutral rating and a $22 price target.